Title |
Cancer Center Support Grant - P30
|
Institution |
UNIVERSITY OF CALIFORNIA DAVIS, DAVIS, CA
|
Principal Investigator |
DEVERE WHITE, RALPH
|
NCI Program Director |
Chad Ellis
|
Cancer Activity |
Multidisciplinary
|
Division |
OCTR
|
Funded Amount |
$2,829,691
|
Project Dates |
07/01/2002 - 06/30/2010
|
Fiscal Year |
2007
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Aging (2.0%)
Behavioral and Social Science (12.0%)
Chemoprevention (1.0%)
Chemotherapy (2.0%)
Childhood Cancers (4.0%)
Genetic Testing (2.0%)
HHV8 (2.0%)
Hematology (15.0%)
Herpes - Other (2.0%)
Hospice (6.0%)
Metastasis (6.0%)
Neurosciences Research (1.0%)
Orphan Drug Research (18.0%)
Taxol (1.0%)
Telehealth (9.0%)
|
Brain (1.0%)
Breast (17.0%)
Cervical Cancer (3.0%)
Colon/Rectum (3.0%)
Head and Neck (Subset of Total Head and Neck) (3.0%)
Leukemia (2.0%)
Liver Cancer (15.0%)
Lung (4.0%)
Non Hodgkins lymphoma (14.0%)
Ovarian Cancer (4.0%)
Pancreas (2.0%)
Prostate (6.0%)
|
Research Type |
Cancer Initiation: Alterations in Chromosomes
Resources and Infrastructure Related to Etiology
Resources and Infrastructure Related to Prevention
Resources and Infrastructure Related to Detection, Diagnosis, or Prognosis
Resources and Infrastructure Related to Treatment and the prevention of recurrence
Resources and Infrastructure Related to Cancer Control, Survivorship, and Outcomes Research
Resources and Infrastructure Related to Scientific Model Systems
|
Abstract |
DESCRIPTION (provided by applicant): The UC Davis Cancer Center, the only NCI-designated cancer center in the Central Valley of California, is the advanced cancer care provider for a population of five million, the only significance point of access to early phase cancer clinical trials in its Northern California region, and together with its collaborator, the Lawrence Livermore National Laboratory [LLNL], the region's principal cancer research organization. Since its founding thirteen years ago, the UC Davis Cancer Center has provided increasingly progressive leadership to, organization of, and support for cancer investigation. In the first sections, we recapitulate briefly the milestones leading up to NCI designation (July 1, 2002). In subsequent sections, we focus on decisions, achievements, and directions characterizing the center's first two years of its Cancer Center Support Grant [CCSG]. In concluding sections, we focus on program and organizational accomplishments, future direction, and geography. |